Cargando…
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
INTRODUCTION: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerc...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802695/ https://www.ncbi.nlm.nih.gov/pubmed/33431378 http://dx.doi.org/10.1136/bmjgh-2020-003248 |
_version_ | 1783635803285487616 |
---|---|
author | Forrer, Armelle Wanji, Samuel Obie, Elisabeth Dibando Nji, Theobald Mue Hamill, Louise Ozano, Kim Piotrowski, Helen Dean, Laura Njouendou, Abdel J Ekanya, Relindis Ndongmo, Winston Patrick Chounna Fung, Ebua Gallus Nnamdi, Dum-Buo Abong, Raphael A Beng, Amuam Andrew Eyong, Mathias Esum Ndzeshang, Bertrand L Nkimbeng, Desmond Akumtoh Teghen, Samuel Suireng, Anicetus Ashu, Ernerstine Ebot Kah, Emmanuel Murdoch, Michele M Thomson, Rachael Theobald, Sally Enyong, Peter Turner, Joseph D Taylor, Mark J |
author_facet | Forrer, Armelle Wanji, Samuel Obie, Elisabeth Dibando Nji, Theobald Mue Hamill, Louise Ozano, Kim Piotrowski, Helen Dean, Laura Njouendou, Abdel J Ekanya, Relindis Ndongmo, Winston Patrick Chounna Fung, Ebua Gallus Nnamdi, Dum-Buo Abong, Raphael A Beng, Amuam Andrew Eyong, Mathias Esum Ndzeshang, Bertrand L Nkimbeng, Desmond Akumtoh Teghen, Samuel Suireng, Anicetus Ashu, Ernerstine Ebot Kah, Emmanuel Murdoch, Michele M Thomson, Rachael Theobald, Sally Enyong, Peter Turner, Joseph D Taylor, Mark J |
author_sort | Forrer, Armelle |
collection | PubMed |
description | INTRODUCTION: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. METHODS: A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in South-West Cameroon. A mixed-methods approach was used. Associations between infection levels, skin disease and adherence to CDTI were assessed using mixed regression modelling. Different community members’ perception and acceptability of the CDTI strategy was explored using semi-structured interviews. RESULTS: Onchocerciasis prevalence was 44.4% among 9456 participants. 17.5% of adults were systematic non-adherers and 5.9% participated in ≥75% of CDTI rounds. Skin disease affected 1/10 participants, including children. Increasing self-reported adherence to CDTI was associated with lower infection levels in participants aged ≥15 years but not in children. Adherence to CDTI was positively influenced by perceived health benefits, and negatively influenced by fear of adverse events linked with economic loss. Concern of lethal adverse events was a common reason for systematic non-adherence. CONCLUSION: CDTI alone is unlikely to achieve elimination in those high transmission areas where low participation is commonly associated with the fear of adverse events, despite the current quasi absence of high-risk levels of loiasis. Such persisting historical memories and fear of ivermectin might impact adherence to CDTI also in areas with historical presence but current absence of loiasis. Because such issues are unlikely to be tackled by CDTI adaptive measures, alternative strategies are needed for onchocerciasis elimination where negative perception of ivermectin is an entrenched barrier to community participation in programmes. |
format | Online Article Text |
id | pubmed-7802695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78026952021-01-21 Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon Forrer, Armelle Wanji, Samuel Obie, Elisabeth Dibando Nji, Theobald Mue Hamill, Louise Ozano, Kim Piotrowski, Helen Dean, Laura Njouendou, Abdel J Ekanya, Relindis Ndongmo, Winston Patrick Chounna Fung, Ebua Gallus Nnamdi, Dum-Buo Abong, Raphael A Beng, Amuam Andrew Eyong, Mathias Esum Ndzeshang, Bertrand L Nkimbeng, Desmond Akumtoh Teghen, Samuel Suireng, Anicetus Ashu, Ernerstine Ebot Kah, Emmanuel Murdoch, Michele M Thomson, Rachael Theobald, Sally Enyong, Peter Turner, Joseph D Taylor, Mark J BMJ Glob Health Original Research INTRODUCTION: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. METHODS: A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in South-West Cameroon. A mixed-methods approach was used. Associations between infection levels, skin disease and adherence to CDTI were assessed using mixed regression modelling. Different community members’ perception and acceptability of the CDTI strategy was explored using semi-structured interviews. RESULTS: Onchocerciasis prevalence was 44.4% among 9456 participants. 17.5% of adults were systematic non-adherers and 5.9% participated in ≥75% of CDTI rounds. Skin disease affected 1/10 participants, including children. Increasing self-reported adherence to CDTI was associated with lower infection levels in participants aged ≥15 years but not in children. Adherence to CDTI was positively influenced by perceived health benefits, and negatively influenced by fear of adverse events linked with economic loss. Concern of lethal adverse events was a common reason for systematic non-adherence. CONCLUSION: CDTI alone is unlikely to achieve elimination in those high transmission areas where low participation is commonly associated with the fear of adverse events, despite the current quasi absence of high-risk levels of loiasis. Such persisting historical memories and fear of ivermectin might impact adherence to CDTI also in areas with historical presence but current absence of loiasis. Because such issues are unlikely to be tackled by CDTI adaptive measures, alternative strategies are needed for onchocerciasis elimination where negative perception of ivermectin is an entrenched barrier to community participation in programmes. BMJ Publishing Group 2021-01-11 /pmc/articles/PMC7802695/ /pubmed/33431378 http://dx.doi.org/10.1136/bmjgh-2020-003248 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Forrer, Armelle Wanji, Samuel Obie, Elisabeth Dibando Nji, Theobald Mue Hamill, Louise Ozano, Kim Piotrowski, Helen Dean, Laura Njouendou, Abdel J Ekanya, Relindis Ndongmo, Winston Patrick Chounna Fung, Ebua Gallus Nnamdi, Dum-Buo Abong, Raphael A Beng, Amuam Andrew Eyong, Mathias Esum Ndzeshang, Bertrand L Nkimbeng, Desmond Akumtoh Teghen, Samuel Suireng, Anicetus Ashu, Ernerstine Ebot Kah, Emmanuel Murdoch, Michele M Thomson, Rachael Theobald, Sally Enyong, Peter Turner, Joseph D Taylor, Mark J Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title | Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title_full | Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title_fullStr | Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title_full_unstemmed | Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title_short | Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon |
title_sort | why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in south-west cameroon |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802695/ https://www.ncbi.nlm.nih.gov/pubmed/33431378 http://dx.doi.org/10.1136/bmjgh-2020-003248 |
work_keys_str_mv | AT forrerarmelle whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT wanjisamuel whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT obieelisabethdibando whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT njitheobaldmue whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT hamilllouise whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT ozanokim whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT piotrowskihelen whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT deanlaura whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT njouendouabdelj whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT ekanyarelindis whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT ndongmowinstonpatrickchounna whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT fungebuagallus whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT nnamdidumbuo whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT abongraphaela whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT bengamuamandrew whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT eyongmathiasesum whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT ndzeshangbertrandl whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT nkimbengdesmondakumtoh whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT teghensamuel whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT suirenganicetus whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT ashuernerstineebot whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT kahemmanuel whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT murdochmichelem whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT thomsonrachael whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT theobaldsally whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT enyongpeter whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT turnerjosephd whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon AT taylormarkj whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon |